After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
NUVB belongs to the Healthcare sector of the NYSE while operating in the Biotechnology industry. The current market capitalization of Nuvation Bio Inc is $796.39M. A total of 4.25 million shares were traded on the day, compared to an average of 6.04M shares.
In the most recent transaction, Markel Stacy bought 10,000 shares of NUVB for 1.71 per share on Jun 18 ’25. After the transaction, the CHIEF PEOPLE OFFICER now owns 29,591 company shares. In a previous transaction on Jun 17 ’25, Sauvage Philippe bought 4,000 shares at 1.79 per share. NUVB shares that Chief Financial Officer owns now total 9,902.
Among the insiders who bought shares, Sauvage Philippe acquired of 3,300 shares on Jun 16 ’25 at a per-share price of $1.83. This resulted in the Chief Financial Officer holding 5,902 shares of NUVB after the transaction. In another insider transaction, Sjogren Colleen bought 50,000 shares at $1.81 per share on Jun 16 ’25. Company shares held by the Chief Commercial Officer now total 81,000.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, NUVB has a high of $3.45 and a low of $1.54.
As of this writing, NUVB has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 1.0 estimates, with a high estimate of -$0.15 per share and a lower estimate of -$0.15. The company reported an EPS of -$0.12 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. NUVB’s latest balance sheet shows that the firm has $765.39M in Cash & Short Term Investments as of fiscal 2021. There were $3.06M in debt and $16.93M in liabilities at the time. Its Book Value Per Share was $1.10, while its Total Shareholder’s Equity was $746.00M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NUVB is Buy with a score of 4.86.
